Alterations in homologous recombination repair genes in prostate

SPOP mutation leads to genomic instability in prostate cancer

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial - The Lancet Oncology

Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer.

Clinical implications of homologous recombination repair mutations in prostate cancer - Cresta Morgado - 2022 - The Prostate - Wiley Online Library

Genetic changes associated with prostate cancer tumorigenesis

Alterations in homologous recombination repair genes in prostate cancer brain metastases

Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes

DNA double-strand break repair by homologous recombination. Coordinated

Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer